Characterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephalitis virus in mice

Vaccine

Volumn 31, Issue 38, 2013, Pages 4136-4142

  Li, Jieqiong ^a   Chen, Hui ^a   Wu, Na ^a   Fan, Dongying ^a   Liang, Guodong ^b   Gao, Na ^a   An, Jing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE FOR VIRAL DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Dentritic cell; DNA vaccine; Inactivated vaccine; Japanese encephalitis virus; Live attenuated vaccine; Regulatory T cell

Indexed keywords

CHIMERIVAX JE; DNA VACCINE; INACTIVATED VIRUS VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; VACCINATION; VERO CELL;

DENTRITIC CELL; DNA VACCINE; INACTIVATED VACCINE; JAPANESE ENCEPHALITIS VIRUS; LIVE ATTENUATED VACCINE; REGULATORY T CELL;

ANIMALS; DENDRITIC CELLS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; JAPANESE ENCEPHALITIS VACCINES; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; VACCINES, ATTENUATED; VACCINES, DNA; VACCINES, INACTIVATED;

EID: 84881554497     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.099     Document Type: Article

References (34)

1. Japanese encephalitis vaccines. Wkly Epidemiol Rec 2006;81(August (34/35)):331-40.
2. van den Hurk A.F., Ritchie S.A., Mackenzie J.S. Ecology and geographical expansion of Japanese encephalitis virus. Annu Rev Entomol 2009, 54:17-35.
3. Mackenzie J.S., Gubler D.J., Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004, 10(December (12 Suppl)):S98-S109.
4. Chambers T.J., Nestorowicz A., Mason P.W., Rice C.M. Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J Virol 1999, 73(April (4)):3095-3101.
5. Halstead S.B., Thomas S.J. Japanese encephalitis: new options for active immunization. Clin Infect Dis 2010, 50(April (8)):1155-1164.
6. Tandan J.B., Ohrr H., Sohn Y.M., Yoksan S., Ji M., Nam C.M., et al. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine 2007, 25(June (27)):5041-5045.
7. Sohn Y.M., Park M.S., Rho H.O., Chandler L.J., Shope R.E., Tsai T.F. Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants. Vaccine 1999, 17(May (18)):2259-2264.
8. Kumar R., Tripathi P., Rizvi A. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. N Engl J Med 2009, 360(April (14)):1465-1466.
9. Chotpitayasunondh T., Sohn Y.M., Yoksan S., Min J., Ohrr H. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand. J Med Assoc Thai 2011, 94(August (Suppl 3)):S195-S203.
10. Kutzler M.A., Weiner D.B. DNA vaccines: ready for prime time?. Nat Rev Genet 2008, 9(October (10)):776-788.
11. Kaur R., Sachdeva G., Vrati S. Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. J Infect Dis 2002, 185(January (1)):1-12.
12. Chen H.W., Pan C.H., Liau M.Y., Jou R., Tsai C.J., Wu H.J., et al. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 1999, 73(December (12)):10137-10145.
13. Bharati K., Rani R., Vrati S. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta]. Vaccine 2009, 27(January (1)):10-16.
14. Chen H., Gao N., Fan D., Wu J., Zhu J., Li J., et al. Suppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in mice. PLoS ONE 2012, 7(4):e34602.
15. Xin Y.Y., Ming Z.G., Peng G.Y., Jian A., Min L.H. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 1988, 39(August (2)):214-217.
16. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988, 319(September (10)):608-614.
17. Poland J.D., Cropp C.B., Craven R.B., Monath T.P. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis 1990, 161(May (5)):878-882.
18. Srivastava A.K., Putnak J.R., Lee S.H., Hong S.P., Moon S.B., Barvir D.A., et al. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine 2001, 19(August (31)):4557-4565.
19. Gao N., Chen W., Zheng Q., Fan D.Y., Zhang J.L., Chen H., et al. Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination. Immunol Lett 2010, 129(March (1)):23-31.
20. Konishi E., Yamaoka M., Khin Sane W., Kurane I., Takada K., Mason P.W. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes. J Virol 1999, 73(July (7)):5527-5534.
21. Li M., Y Y., Liu X., Xu H., Jia L., Wang Z., et al. Comparative study on the cellular immune response induced by live attenuated SA14-14-2 Japanese encephalitis vaccine and inactivated Japanese encephalitis vaccine in mice. Chin J Vaccines Immunization 2010, 16(August (4)):334-339.
22. Liu X., Yu Y., Li M., Liang G., Wang H., Jia L., et al. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China. Vaccine 2011, 29(March (11)):2127-2130.
23. Olsen S.J., Supawat K., Campbell A.P., Anantapreecha S., Liamsuwan S., Tunlayadechanont S., et al. Japanese encephalitis virus remains an important cause of encephalitis in Thailand. Int J Infect Dis 2010, 14(October (10)):e888-e892.
24. Yu Y. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Vaccine 2010, 28(May (21)):3635-3641.
25. Knolle P.A., Uhrig A., Hegenbarth S., Loser E., Schmitt E., Gerken G., et al. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol 1998, 114(December (3)):427-433.
26. McBride J.M., Jung T., de Vries J.E., Aversa G. IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. Cell Immunol 2002, 215(February (2)):162-172.
27. Aleyas A.G., George J.A., Han Y.W., Rahman M.M., Kim S.J., Han S.B., et al. Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways. J Immunol 2009, 183(August (4)):2462-2474.
28. Cao S., Li Y., Ye J., Yang X., Chen L., Liu X., et al. Japanese encephalitis Virus wild strain infection suppresses dendritic cells maturation and function, and causes the expansion of regulatory T cells. Virol J 2011, 8:39.
29. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
30. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6(April (4)):345-352.
31. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4(April (4)):330-336.
32. Surls J., Nazarov-Stoica C., Kehl M., Casares S., Brumeanu T.D. Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination. Vaccine 2010, 28(October (45)):7319-7330.
33. Wang S.M., Tsai M.H., Lei H.Y., Wang J.R., Liu C.C. The regulatory T cells in anti-influenza antibody response post influenza vaccination. Hum Vaccin Immunother 2012, 8(September (9)):1243-1249.
34. Maynard C.L., Weaver C.T. Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol Rev 2008, 226(December):219-233.